The rationale is that GLP-1 receptor agonists can reduce B12 absorption over time due to their effects on gastric acid production and gut motility
dose reduction of these medications may be needed) [1] Acute kidney injury risk, particularly with severe gastrointestinal adverse reactions causing dehydration Diabetic retinopathy complications , particularly in patients with a history of retinopathy who experience rapid improvement in blood glucose [1] Acute gallbladder disease including cholelithiasis and cholecystitis The FDA label includes a boxed warning about thyroid C-cell tumors observed in rodent studies, though the relevance to humans remains uncertain
Speak with one of our healthcare specialists today to discuss your options and find the right care for you
New study points to a possible link Preclinical studies, small controlled trials, and observational research further suggest that GLP-1 receptor agonists may have beneficial effects in the prevention and treatment of mood disorders and in psychopathology domains that substantially impair quality of life, including cognitive dysfunction and anhedonia
If you are comparing Retatrutide to other peptide treatments, understanding dosing differences matters